IL-6, an inflammatory cytokine, is highly expressed in HCC patients and is implicated in HCC occurrence and development via the regulation of IL-6R/gp130/STAT3 signaling [17, 38]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.